Malaysia-based Yakin Medic plans to raise RM100 million from an IPO on the Catalist board of the Singapore Exchange , reports The Star, The Sun and various other Malaysian papers. The IPO, targeted ...
U.S. IPO Weekly Recap: Small Asia-Based Names List, As TV Adtech MNTN And Others Join The Pipeline
Inflammation biotech Apimeds Pharmaceuticals US ( APUS) is tentatively scheduled to raise $20 million at a $58 million market cap. The company is developing Apitox, an intradermally administered bee ...
Temasek-backed companies should not face obligation to list in Singapore: Chee
COMPANIES should not be obliged to list on the Singapore Exchange (SGX), said Second Minister for Finance Chee Hong Tat on Friday (Feb 28), in response to Workers’ Party Member of Parliament Louis ...
New MAS measures signpost Singapore stock market’s importance, says SGX’s Head of Equities
Ng Yao Loong, Head of Equities at the Singapore Exchange, discusses the Monetary Authority of Singapore's proposed new scheme to boost SGX-listed Singaporean equities.
Yakin Medic sets sights on global growth with Singapore IPO plan
ONE of Malaysia's leading providers of active live stem cell therapies, Yakin Medic Sdn Bhd, is set to expand into new markets as part of its broader growth strategy.
Singapore’s fiscal strength is a competitive advantage, not detrimental to Singaporeans: PM Wong
SINGAPORE’S fiscal strength is a “vital source of competitive advance”, and unexpected surpluses are better than surprise shortfalls, said Finance Minister and Prime Minister Lawrence Wong, rounding ...
Singapore’s richest clan in crisis over public father-son feud
Even by the standards of Asian succession dramas, the family feud raging at the Kwek dynasty, who run Singapore’s biggest listed developer, is striking.
Olam Group’s profit drops on rising commodity prices, finance costs
Singapore's Olam Group reported a slump in its full-year underlying profit on Friday, impacted by an increase in net finance costs coupled with a sharp rise in prices of commodities such as cocoa and ...
Singapore’s Olam Group reports around 53% fall in full-year profit
Singapore's Olam Group reported a slump in its underlying profit for the year on Friday, impacted by an increase in its net finance costs.
Singapore stocks rise 0.3% despite Yangzijiang Shipbuilding dive
The three local banks had a mixed showing, with DBS declining while OCBC and UOB advanced. Read more at straitstimes.com.
Moglix Secures $12.3 Mn from Singapore Parent Amid Plans for India Domicile Shift and IPO
Credlix provides SMEs in sectors like electronics, automotive, textiles, and aerospace components with collateral-free lending options. This action demonstrates Moglix’s goal of becoming a world ...
Singapore can be ‘bridge-builder’ in more fragmented world by serving as trusted innovation hub: DPM Heng
Mr Heng Swee Keat, who chairs the National Research Foundation and Future Economy Advisory Panel, also announced two major new initiatives for the Research, Innovation and Enterprise (RIE) sector from ...
Budget 2025: Increased investments in research, innovation, enterprise will benefit economy and society: Heng Swee Keat
Singapore has much to celebrate this year with SG60, but we must be aware of the rapidly changing global landscape and invest in creating our future, said Deputy Prime Minister Heng Swee Keat on ...
FII-backed pharma stock: Company acquires 10k shares of Singapore subsidiary; up 335% in 1 yr
Mumbai-based Sudarshan Pharma Industries is a smallcap company, engaged in specialty chemicals and intermediates for various sectors. Its shares have delivered an impressive return of 335 per cent in ...
CapitaLand Investment posts second-half profit rebound; proposes dividend-in-specie of CICT units
SINGAPORE - Real estate investment manager CapitaLand Investment (CLI) bounced back into profit in the second half of 2024, proposing a special dividend in the form of units in its biggest Reit and a ...
335% Jump In 1 Yr: Multibagger Penny Stock Expands Global Footprint With Singapore Subsidiary Acquisition
For an estimated S$10,000, Sudarshan Pharma Industries Limited (SPIL) purchased 10,000 shares in the pharmaceutical firm owned by Amar Ashok Vyas.